Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
fabrizio.conti@uniroma1.it
Fabrizio Conti
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
fabrizio.conti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors
JOURNAL OF AUTOIMMUNITY
2020
Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2020
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
ANNALS OF THE RHEUMATIC DISEASES
2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting
ARTHRITIS & RHEUMATOLOGY
2020
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
SCIENCE IMMUNOLOGY
2020
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
AUTOIMMUNITY REVIEWS
2020
Remission in systemic lupus erythematosus: Testing different definitions in a large multicentre cohort
ANNALS OF THE RHEUMATIC DISEASES
2020
Janus kinases inhibitors for treating patients with rhupus
JOINT BONE SPINE
2020
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort
RHEUMATOLOGY
2020
Native/citrullinated LL37-specific T-cells help autoantibody production in systemic lupus erythematosus
SCIENTIFIC REPORTS
2020
Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA.hy926 endothelial cell line
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2020
Autophagy modulation in lymphocytes from COVID-19 patients. new therapeutic target in SARS-COV-2 infection
FRONTIERS IN PHARMACOLOGY
2020
Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2020
Autophagy occurs in lymphocytes infiltrating sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions
ARTHRITIS RESEARCH & THERAPY
2020
Validation of thymic stromal lymphopoietin as a biomarker of primary sjogren's syndrome and related lymphoproliferation. results in independent cohorts
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2020
Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
2019
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs
ARTHRITIS RESEARCH & THERAPY
2019
Correction: Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models (PLoS ONE (2018) 13: 12 (e0207926) DOI: 10.1371/journal.pone.0207926)
PLOS ONE
2019
Dietary Habits Bursting into the Complex Pathogenesis of Autoimmune Diseases: The Emerging Role of Salt from Experimental and Clinical Studies
NUTRIENTS
2019
Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome
FRONTIERS IN IMMUNOLOGY
2019
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
Progetti di Ricerca
MODULATION OF NEURO-IMMUNE INTERACTION THROUGH JAK INHIBITION IN RHEUMATOID ARTHRITIS
Characterization of regulatory T cells in psoriatic arthritis patients: role of type I interferons in restraining cAMP-mediated immune suppression, and implications for metabolic inflammation.
Activation of salivary gland epithelial cells from different subset of patients with primary Sjögren syndrome: towards a personalized medicine
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma